The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Mangano Ross J since 2006.
The trader's CIK number is 1013724.
At the time of the last reporting, Mangano Ross J was the Director of Ani Pharmaceuticals Inc. (stock ticker symbol ANIP).
Also see all insider trading activities at Ani Pharmaceuticals Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2014 | ANIP | 5,000 | $143,236 | 0 | $0 | 0 | $0 |
2013 | ANIP | 19,000 | $176,090 | 0 | $0 | 0 | $0 |
2011 | ANIP | 105,000 | $236,800 | 0 | $0 | 0 | $0 |
2010 | ANIP | 20,000 | $29,400 | 0 | $0 | 0 | $0 |
2008 | ANIP | 90,000 | $269,995 | 0 | $0 | 0 | $0 |
2007 | ANIP | 75,000 | $284,200 | 0 | $0 | 0 | $0 |
2006 | ANIP | 143,600 | $244,981 | 0 | $0 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2014-09-15 | ANIP | Buy | 3,000 | 27.49 | 82,476 |
2014-05-07 | ANIP | Buy | 2,000 | 30.38 | 60,760 |
2013-11-07 | ANIP | Buy | 9,000 | 11.27 | 101,430 |
2013-08-20 | ANIP | Buy | 10,000 | 7.47 | 74,660 |
2011-08-12 | BPAX | Buy | 25,000 | 2.40 | 60,000 |
2011-08-05 | BPAX | Buy | 80,000 | 2.21 | 176,800 |
2010-12-07 | BPAX | Buy | 20,000 | 1.47 | 29,400 |
2008-12-29 | BPAX | Buy | 25,000 | 1.19 | 29,675 |
2008-05-12 | BPAX | Buy | 15,000 | 3.59 | 53,820 |
2008-01-04 | BPAX | Buy | 50,000 | 3.73 | 186,500 |
2007-12-20 | BPAX | Buy | 25,000 | 3.98 | 99,500 |
2007-12-19 | BPAX | Buy | 50,000 | 3.69 | 184,700 |
2006-12-26 | BPA | Buy | 15,000 | 2.69 | 40,365 |
2006-11-16 | BPA | Buy | 100,000 | 1.50 | 150,000 |
2006-07-19 | BPA | Buy | 14,800 | 1.90 | 28,120 |
2006-07-14 | BPA | Buy | 13,800 | 1.92 | 26,496 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mangano Ross J (Director of Ani Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.